findmyKOL
Clinical trialNCT06229678RecruitingEarly phase 1Interventional

Ketones, SGLT2, HFrEF

SponsorThe University of Texas Health Science Center at San AntonioEnrollment71Heart Failure With Reduced Ejection FractionType2diabetes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Texas Diabetes Institute - University Health System

    San Antonio, Texas, United States

    Jemema Rajan, MDRalph DeFronzo, MD →Sivaram Neppala, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jan 2024
Primary completion
1 Nov 2026
Completion
1 Mar 2027
Last update posted
5 Feb 2026
Registered enrollment
71
Registry id
NCT06229678
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.